Immuneering Corp IMRX

Immuneering Stock Price Forecast. Should You Buy IMRX?

StockInvest.us · 2026-08-21

Immuneering (IMRX) Upgraded to Buy: Here's What You Should Know

Yahoo Finance · 2026-07-15

IMRX Stock On Track For Worst Day In Nearly 5 Months — What’s Driving The Selloff?

TradingView · 2026-06-01

Immuneering’s New CFO Gets 650,000-Share Option With $4.78 Exercise Price

Stock Titan · 2026-07-17

Cantor Fitzgerald initiates Immuneering stock with overweight rating

Investing.com · 2026-07-08

Immuneering Corporation: Updates Inbound At The End Of The Month (NASDAQ:IMRX)

Seeking Alpha · 2026-05-12

Immuneering Q2 Loss Widens as Cash Runway Extends Into 2029

Quiver Quantitative · 2026-08-05

IMRX Jumps As Immuneering Extends Cash Runway And Trial Pipeline

StocksToTrade · 2026-05-22

Insider Buyers At Immuneering Sitting On US$361k Profit

simplywall.st · 2026-05-02

Immuneering Corp (IMRX) CFO discloses 225,000 Class A shares

Stock Titan · 2026-07-16

Immuneering: A Third (Much Cheaper) Way To Invest In The RAS-RAF-MEK-ERK 'Revolution'

Seeking Alpha · 2026-07-27

IMRX Forecast — Price Target — Prediction for 2027

TradingView · 2026-06-25

Immuneering stock maintained at Outperform by Oppenheimer on survival data

Investing.com · 2026-06-01

Immuneering Corporation to Present Phase 2a Trial Results for Atebimetinib at ASCO Annual Meeting on June 1, 2026

Quiver Quantitative · 2026-05-21

Why Immuneering (IMRX) Is Down 29.7% After Positive Phase 2a Pancreatic Cancer Survival Update And What's Next

Yahoo Finance · 2026-01-10

Show 10 more ↓

Upstream Bio, Inc. (UPB) UPB Trevi Therapeutics, Inc. (TRVI) TRVI Neuphoria Therapeutics Inc. (NEUP) NEUP Nuvation Bio Inc. (NUVB) NUVB BELITE BIO, INC (BLTE) BLTE